Eric Soyer

Eric Soyer serves as the Chief Financial Officer at MaaT Pharma since November 2024. Prior to this role, Eric held various significant positions at Phaxiam Therapeutics from September 2015 to September 2024, including Directeur Général Délégué, COO, and CFO. Eric also contributed to ERYTECH in multiple capacities, including CFO and COO. Before these roles, Eric was the Managing Director at EDAP TMS France from May 2012 to September 2015 and served as VP Finance and CFO at EDAP TMS from December 2006 to September 2015. Eric's earlier experience includes the role of Chief Financial Officer at MEDICA and managerial positions at APRIL GROUP. Eric began their career at MICHELIN as a controller. Educational qualifications include an Executive MBA from HEC Paris, an MBA in Finance from the University of Kansas, and business training at Clermont School of Business.